Javier Antoñanzas , Jorge María Núñez-Córdoba , Rafael Salido-Vallejo , Laura Álvarez-Gigli , Ramón Robledano , Agustín España
{"title":"环状肉芽肿患者脂肪蛋白表达与血脂异常风险之间的关系","authors":"Javier Antoñanzas , Jorge María Núñez-Córdoba , Rafael Salido-Vallejo , Laura Álvarez-Gigli , Ramón Robledano , Agustín España","doi":"10.1016/j.medcle.2024.01.041","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><p>An association between granuloma annulare (GA) and dyslipidaemia has been reported. Adipophilin expression may play a plausible role as a cutaneous biomarker for dyslipidaemia in patients with GA; however, this potential link remains to be explored.</p></div><div><h3>Methods</h3><p>Patients with GA were identified at our hospital between January 1, 1990, and December 31, 2021, with a thorough review of their clinical and histological characteristics. Adipophilin staining was assessed in biopsies of GA lesions.</p></div><div><h3>Results</h3><p>A total of 107 patients with GA were included. The prevalence of dyslipidaemia in patients with positive adipophilin staining was clearly higher than in those with negative labelling (62.3% vs 13.3%). Relative to the dyslipidaemia risk for patients with negative adipophilin expression, the odds for patients with positive adipophilin expression were increased 10-fold (OR: 10.8; <em>p</em>-value<!--> <!--><<!--> <!-->.01). We identified 23 incident cases of dyslipidaemia over a median follow-up period of 91 months among 54 patients with no history of dyslipidaemia. The patients with positive adipophilin expression showed a higher risk of developing dyslipidaemia (HR: 8.9; <em>p</em>-value<!--> <!--><<!--> <!-->.01).</p></div><div><h3>Conclusions</h3><p>Patients with positive adipophilin staining in their GA biopsies were found to be associated with a higher risk for both baseline and incident dyslipidaemia.</p></div>","PeriodicalId":74154,"journal":{"name":"Medicina clinica (English ed.)","volume":"163 5","pages":"Pages 232-237"},"PeriodicalIF":0.0000,"publicationDate":"2024-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association between adipophilin expression and risk of dyslipidaemia in patients with granuloma annulare\",\"authors\":\"Javier Antoñanzas , Jorge María Núñez-Córdoba , Rafael Salido-Vallejo , Laura Álvarez-Gigli , Ramón Robledano , Agustín España\",\"doi\":\"10.1016/j.medcle.2024.01.041\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background</h3><p>An association between granuloma annulare (GA) and dyslipidaemia has been reported. Adipophilin expression may play a plausible role as a cutaneous biomarker for dyslipidaemia in patients with GA; however, this potential link remains to be explored.</p></div><div><h3>Methods</h3><p>Patients with GA were identified at our hospital between January 1, 1990, and December 31, 2021, with a thorough review of their clinical and histological characteristics. Adipophilin staining was assessed in biopsies of GA lesions.</p></div><div><h3>Results</h3><p>A total of 107 patients with GA were included. The prevalence of dyslipidaemia in patients with positive adipophilin staining was clearly higher than in those with negative labelling (62.3% vs 13.3%). Relative to the dyslipidaemia risk for patients with negative adipophilin expression, the odds for patients with positive adipophilin expression were increased 10-fold (OR: 10.8; <em>p</em>-value<!--> <!--><<!--> <!-->.01). We identified 23 incident cases of dyslipidaemia over a median follow-up period of 91 months among 54 patients with no history of dyslipidaemia. The patients with positive adipophilin expression showed a higher risk of developing dyslipidaemia (HR: 8.9; <em>p</em>-value<!--> <!--><<!--> <!-->.01).</p></div><div><h3>Conclusions</h3><p>Patients with positive adipophilin staining in their GA biopsies were found to be associated with a higher risk for both baseline and incident dyslipidaemia.</p></div>\",\"PeriodicalId\":74154,\"journal\":{\"name\":\"Medicina clinica (English ed.)\",\"volume\":\"163 5\",\"pages\":\"Pages 232-237\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-09-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medicina clinica (English ed.)\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2387020624003693\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicina clinica (English ed.)","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2387020624003693","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
摘要
背景据报道,环状肉芽肿(GA)与血脂异常之间存在关联。嗜脂素的表达可能是GA患者血脂异常的皮肤生物标志物,但这种潜在的联系仍有待探索。方法对1990年1月1日至2021年12月31日期间我院收治的GA患者进行鉴定,并对其临床和组织学特征进行全面审查。结果 共纳入 107 名 GA 患者。脂肪素染色阳性患者的血脂异常发生率明显高于阴性患者(62.3% 对 13.3%)。相对于嗜脂素阴性患者的血脂异常风险,嗜脂素阳性患者的血脂异常风险增加了 10 倍(OR:10.8;p-value <.01)。在中位 91 个月的随访期间,我们在 54 名无血脂异常病史的患者中发现了 23 例血脂异常病例。结论在 GA 活检中发现嗜脂素染色阳性的患者患基线和偶发血脂异常的风险较高。
Association between adipophilin expression and risk of dyslipidaemia in patients with granuloma annulare
Background
An association between granuloma annulare (GA) and dyslipidaemia has been reported. Adipophilin expression may play a plausible role as a cutaneous biomarker for dyslipidaemia in patients with GA; however, this potential link remains to be explored.
Methods
Patients with GA were identified at our hospital between January 1, 1990, and December 31, 2021, with a thorough review of their clinical and histological characteristics. Adipophilin staining was assessed in biopsies of GA lesions.
Results
A total of 107 patients with GA were included. The prevalence of dyslipidaemia in patients with positive adipophilin staining was clearly higher than in those with negative labelling (62.3% vs 13.3%). Relative to the dyslipidaemia risk for patients with negative adipophilin expression, the odds for patients with positive adipophilin expression were increased 10-fold (OR: 10.8; p-value < .01). We identified 23 incident cases of dyslipidaemia over a median follow-up period of 91 months among 54 patients with no history of dyslipidaemia. The patients with positive adipophilin expression showed a higher risk of developing dyslipidaemia (HR: 8.9; p-value < .01).
Conclusions
Patients with positive adipophilin staining in their GA biopsies were found to be associated with a higher risk for both baseline and incident dyslipidaemia.